STOCK TITAN

AcariaHealth Sparks Innovation at 2025 Healthcare Advocate Summit with Hackathon and Expert Panels

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

AcariaHealth, a specialty pharmacy solutions provider and Centene Corporation (NYSE: CNC) subsidiary, will host multiple sessions at the 2025 Healthcare Advocate Summit in Las Vegas from September 2-5, 2025.

The company will lead a pioneering "Reimagine Access" Hackathon featuring themed breakout discussions on healthcare access challenges, including biosimilars, home infusion, and Medicare/Medicaid access. Additionally, AcariaHealth will present an expert panel on biosimilars and market disruption, and a roundtable discussion on the Medicare Prescription Payment Plan (M3P).

Led by CEO Jessica Ciccolella-Kahl, these sessions demonstrate AcariaHealth's commitment to improving healthcare access through innovation and advocacy in specialty pharmacy services.

AcariaHealth, fornitore di soluzioni per farmacie specialistiche e controllata di Centene Corporation (NYSE: CNC), ospiterà più sessioni al 2025 Healthcare Advocate Summit a Las Vegas dal 2 al 5 settembre 2025.

L'azienda guiderà un innovativo "Reimagine Access" Hackathon con discussioni a tema su sfide di accesso alla salute, inclusi biosimilari, infusioni domiciliari e accesso a Medicare/Medicaid. Inoltre, AcariaHealth presenterà un panel di esperti sui biosimilari e le disruptive del mercato, e una tavola rotonda sul Medicare Prescription Payment Plan (M3P).

Guidate dalla CEO Jessica Ciccolella-Kahl, queste sessioni dimostrano l'impegno di AcariaHealth nel migliorare l'accesso alle cure attraverso l'innovazione e l'advocacy nei servizi di farmacia specializzata.

AcariaHealth, proveedor de soluciones para farmacias especializadas y filial de Centene Corporation (NYSE: CNC), organizará varias sesiones en el 2025 Healthcare Advocate Summit en Las Vegas del 2 al 5 de septiembre de 2025.

La compañía encabezará un innovador "Reimagine Access" Hackathon con mesas de trabajo temáticas sobre los retos de acceso a la atención sanitaria, incluidos los biosimilares, la infusión domiciliaria y el acceso a Medicare/Medicaid. Además, AcariaHealth presentará un panel de expertos sobre biosimilares y la disrupción del mercado, y una mesa redonda sobre el Medicare Prescription Payment Plan (M3P).

Bajo la dirección de la CEO Jessica Ciccolella-Kahl, estas sesiones muestran el compromiso de AcariaHealth para mejorar el acceso a la atención mediante la innovación y la defensa en los servicios de farmacia especializada.

AcariaHealth는 전문 약국 솔루션 제공업체이자 Centene Corporation (NYSE: CNC)의 자회사로, 2025년 9월 2일부터 5일까지 라스베이거스에서 열리는 2025 Healthcare Advocate Summit에서 여러 세션을 주최합니다.

회사는 의료 접근성 과제를 주제로 한 분과 토론을 포함한 선도적인 "Reimagine Access" 해커톤을 주관하며, 여기에는 바이오시밀러, 가정 주입(홈 인퓨전), 메디케어/메디케이드 접근성 등이 포함됩니다. 또한 AcariaHealth는 바이오시밀러와 시장 혼란(디스럽션)에 관한 전문가 패널과 Medicare Prescription Payment Plan(M3P)에 관한 원탁 토론을 진행합니다.

CEO 제시카 치콜렐라-칼(Jessica Ciccolella-Kahl)이 이끄는 이러한 세션들은 전문 약국 서비스 분야에서 혁신과 옹호 활동을 통해 의료 접근성을 향상하려는 AcariaHealth의 의지를 보여줍니다.

AcariaHealth, fournisseur de solutions pour pharmacies spécialisées et filiale de Centene Corporation (NYSE: CNC), animera plusieurs sessions au 2025 Healthcare Advocate Summit à Las Vegas du 2 au 5 septembre 2025.

L'entreprise dirigera un pionnier "Reimagine Access" Hackathon comprenant des discussions en sous-groupes thématiques sur les défis d'accès aux soins, notamment les biomédicaments biosimilaires, l'infusion à domicile et l'accès à Medicare/Medicaid. De plus, AcariaHealth présentera un panel d'experts sur les biosimilars et la disruption du marché, ainsi qu'une table ronde sur le Medicare Prescription Payment Plan (M3P).

Menées par la PDG Jessica Ciccolella-Kahl, ces sessions illustrent l'engagement d'AcariaHealth à améliorer l'accès aux soins grâce à l'innovation et au plaidoyer dans les services de pharmacie spécialisée.

AcariaHealth, ein Anbieter von Specialty-Pharmacy-Lösungen und Tochtergesellschaft der Centene Corporation (NYSE: CNC), wird mehrere Sitzungen beim 2025 Healthcare Advocate Summit in Las Vegas vom 2. bis 5. September 2025 veranstalten.

Das Unternehmen wird einen wegweisenden "Reimagine Access" Hackathon durchführen, der thematische Breakout-Diskussionen zu Herausforderungen beim Gesundheitszugang umfasst, darunter Biosimilars, Heiminfusionen und Zugang zu Medicare/Medicaid. Außerdem präsentiert AcariaHealth ein Expertengremium zu Biosimilars und Marktdisruption sowie eine Gesprächsrunde zum Medicare Prescription Payment Plan (M3P).

Unter der Leitung der CEO Jessica Ciccolella-Kahl zeigen diese Sitzungen AcariaHealths Engagement, den Zugang zur Gesundheitsversorgung durch Innovation und Interessenvertretung im Bereich der Specialty-Pharmacy-Dienstleistungen zu verbessern.

Positive
  • None.
Negative
  • None.

LAS VEGAS, Aug. 26, 2025 /PRNewswire/ -- AcariaHealth, a leader in specialty pharmacy solutions and a Centene Corporation company (NYSE: CNC), is taking center stage at the 2025 Healthcare Advocate Summit (Sept. 2–5) in Las Vegas with a first-of-its-kind "Reimagine Access" Hackathon and two can't-miss expert sessions.

Reimagine Access: A Hackathon for Healthcare Advocates
Tuesday, Sept. 2 | 1:00–3:30 PM PT | Florentine 1–11

This dynamic, hands-on session brings together healthcare advocates, providers, and pharmacy professionals for fast-paced, themed breakout discussions focused on real-world access challenges:

  • Breaking Bio – Biosimilars & Continuity of Care
  • No Place Like Home – Reimagining Home Infusion
  • Coverage Unlocked – Medicare/Medicaid Access
  • The Access Avengers – SP + Advocate Partnerships
  • Pharmaformers – Transforming Specialty Pharmacy

Guided by AcariaHealth Regional Sales Directors, each table invites participants to brainstorm actionable solutions they can take back to their organizations.

Expert Panel: Biosimilars & Market Disruption
Thursday, Sept. 4 | 1:30–2:20 PM PT

Join AcariaHealth leaders as they break down biosimilar trends, payer mandates, and how to prevent care disruption. Featuring a new video spotlighting our Provider Experience Managers (PEMs) and their impact on provider-pharmacy collaboration.

Panelists:

  • Alysha Robinson, PharmD, CSP – Director, Specialty Pharmacy Program Management
  • Kathleen Stenberg, PharmD, CSP – Lead Specialty Pharmacist, Operational Excellence
  • Robin Waida – Director, Physician Sales
  • Gil Rosas, BSN – Account Executive

Can't attend? Register for our October Biosimilars Webinar.

Roundtable: M3P Unpacked – Your Final Questions, Clarified
Friday, Sept. 5 | 8:30–9:30 AM PT | Pompeian 1–11
Speaker: Sheri Wallace - Account Executive

Wrap up the Summit with this interactive discussion on the Medicare Prescription Payment Plan (M3P) and its implications for patients and advocates. No slides—just your questions answered.

Advancing Access, Together
"At AcariaHealth, we believe access to care should be as seamless as the care itself," said Jessica Ciccolella-Kahl, CEO of AcariaHealth. "We're proud to lead these conversations and help drive lasting solutions."

From biosimilar transitions to breakthrough collaborations, AcariaHealth is committed to reshaping specialty pharmacy through innovation, advocacy, and compassion.

Heading to the Healthcare Advocate Summit? Stop by our sessions, meet the team, and follow us on LinkedIn for live updates.

About AcariaHealth
AcariaHealth is a national specialty pharmacy dedicated to supporting patients with complex conditions through personalized care and clinical expertise. As a Centene company, AcariaHealth leverages the strength of the largest Medicaid managed care organization to deliver transformative outcomes across the country.
Learn more: AcariaHealth.com
Follow us on LinkedIn

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/acariahealth-sparks-innovation-at-2025-healthcare-advocate-summit-with-hackathon-and-expert-panels-302538826.html

SOURCE AcariaHealth

FAQ

When and where is AcariaHealth presenting at the 2025 Healthcare Advocate Summit?

AcariaHealth is presenting multiple sessions at the Summit in Las Vegas from September 2-5, 2025, including a Hackathon on Tuesday, Sept. 2, an expert panel on Thursday, Sept. 4, and a roundtable discussion on Friday, Sept. 5.

What is the 'Reimagine Access' Hackathon by AcariaHealth (NYSE: CNC)?

The 'Reimagine Access' Hackathon is a hands-on session where healthcare advocates, providers, and pharmacy professionals participate in themed breakout discussions focusing on challenges in biosimilars, home infusion, Medicare/Medicaid access, and specialty pharmacy partnerships.

Who are the speakers for AcariaHealth's biosimilar panel at the 2025 Healthcare Summit?

The panel features Alysha Robinson (Director, Specialty Pharmacy Program Management), Kathleen Stenberg (Lead Specialty Pharmacist), Robin Waida (Director, Physician Sales), and Gil Rosas (Account Executive).

What topics will AcariaHealth cover in their M3P roundtable discussion?

The interactive roundtable discussion, led by Account Executive Sheri Wallace, will address questions about the Medicare Prescription Payment Plan (M3P) and its implications for patients and advocates.
Centene Corp Del

NYSE:CNC

CNC Rankings

CNC Latest News

CNC Latest SEC Filings

CNC Stock Data

14.44B
488.78M
0.46%
100.16%
5.66%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
ST LOUIS